Zoetis Inc. (ZTS)

102.94
0.56 0.55
NYSE : Health Technology
Prev Close 102.38
Open 102.37
Day Low/High 101.84 / 103.44
52 Wk Low/High 78.90 / 103.97
Volume 1.06M
Avg Volume 2.04M
Exchange NYSE
Shares Outstanding 478.66M
Market Cap 48.81B
EPS 3.00
P/E Ratio 35.37
Div & Yield 0.66 (0.57%)

Latest News

Wheaton Precious Metals, PetMed Express: 'Mad Money' Lightning Round

Wheaton Precious Metals, PetMed Express: 'Mad Money' Lightning Round

Jim Cramer takes a look at Wheaton Precious Metals, Cirrus Logic, PetMed Express, Knight Transportation, Chart Industries and more.

What to Watch Out For: Cramer's 'Mad Money' Recap (Thursday 5/2/19)

What to Watch Out For: Cramer's 'Mad Money' Recap (Thursday 5/2/19)

Jim Cramer says that although a sell-off can breed a buying opportunity, investors need to worry about sky-high IPOs and other signs of froth.

Zoetis Announces First Quarter 2019 Results

Zoetis Announces First Quarter 2019 Results

Zoetis Inc. (NYSE: ZTS) today reported its financial results for the first quarter of 2019 and updated its guidance for full year 2019.

Forbes Names Zoetis One Of America's Best Employers For Fourth Year In A Row

Forbes Names Zoetis One Of America's Best Employers For Fourth Year In A Row

Zoetis Inc. (NYSE: ZTS), the global leader in animal health, today announced that it has been named one of America's Best Midsize Employers by Forbes Magazine for the fourth year in a row, ranking among the top 150 companies.

Zoetis Becomes #214 Most Shorted S&P 500 Component, Replacing Discovery

Zoetis Becomes #214 Most Shorted S&P 500 Component, Replacing Discovery

The most recent short interest data has been released for the 03/29/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?

Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?

Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.

Zoetis To Host Webcast And Conference Call On First Quarter 2019 Financial Results

Zoetis To Host Webcast And Conference Call On First Quarter 2019 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

Zoetis Named A Top Company For Executive Women By NAFE

Zoetis Named A Top Company For Executive Women By NAFE

Zoetis Inc. (NYSE: ZTS) today announced that it has been named one of the 2019 Top Companies for Executive Women by the National Association for Female Executives.

Zoetis Is in a Strong Uptrend So Don't Expect Much of a Dip to Buy It

Zoetis Is in a Strong Uptrend So Don't Expect Much of a Dip to Buy It

What about the technical story? Let's check out some charts.

3 Pet Product Stocks Ready to Be Unleashed: Dogness, Elanco and Zoetis

3 Pet Product Stocks Ready to Be Unleashed: Dogness, Elanco and Zoetis

Pets can bring significant profits to companies that cater to this niche market.

Don't Underestimate a Trade Deal: Cramer's 'Mad Money' Recap (Friday 02/15/19)

Don't Underestimate a Trade Deal: Cramer's 'Mad Money' Recap (Friday 02/15/19)

Don't underestimate how positive an actual trade deal with China would be for American companies, Jim Cramer argues.

Institutional Selling, Europe's Economy, Nvidia Earnings Preview: Market Recon

Institutional Selling, Europe's Economy, Nvidia Earnings Preview: Market Recon

What trader has never both fallen in love with Nvidia, only to eventually feel the scorn of an angry lover's tortured vengeance?

Zoetis Reports Fourth Quarter And Full Year 2018 Results

Zoetis Reports Fourth Quarter And Full Year 2018 Results

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2018 and provided full year guidance for 2019.

Zoetis Declares Second Quarter 2019 Dividend

Zoetis Declares Second Quarter 2019 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a second quarter 2019 dividend payable to holders of the company's common stock of $0.

Short-Squeezed Ugly Ducklings: Cramer's 'Mad Money' Recap (Wednesday 2/6/19)

Short-Squeezed Ugly Ducklings: Cramer's 'Mad Money' Recap (Wednesday 2/6/19)

Jim Cramer says Wednesday brought multiple positive earnings surprises that prompt us to ask how is it possible that these moves can occur without warning?

Canada Goose, Wix.com, Yext: 'Mad Money' Lightning Round

Canada Goose, Wix.com, Yext: 'Mad Money' Lightning Round

Jim Cramer weighs in on Canada Goose, Wix.com, Yext, Idexx Laboratories, Yeti, Clean Harbors, Nio and more.

Zoetis To Host Webcast And Conference Call On Fourth Quarter And Full Year 2018 Financial Results

Zoetis To Host Webcast And Conference Call On Fourth Quarter And Full Year 2018 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

Zoetis To Participate In The 37th Annual J.P. Morgan Healthcare Conference

Zoetis To Participate In The 37th Annual J.P. Morgan Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the 37th Annual J.

Zoetis Announces Authorization Of $2 Billion Share Repurchase Program

Zoetis Announces Authorization Of $2 Billion Share Repurchase Program

Zoetis Inc. (NYSE: ZTS) today announced that its Board of Directors has authorized a $2 billion multi-year share repurchase program as part of its long-term capital allocation plans.

Markets Are Headed For a More Difficult Environment: Market Recon

Markets Are Headed For a More Difficult Environment: Market Recon

Santa is on his way... A lot of pressure on the jolly fellow this year.

Zoetis Announces Third Quarter 2018 Results

Zoetis Announces Third Quarter 2018 Results

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2018 and updated its guidance for full year 2018.

Zoetis To Participate In The Credit Suisse 27th Annual Healthcare Conference

Zoetis To Participate In The Credit Suisse 27th Annual Healthcare Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Credit Suisse 27th Annual Healthcare Conference on Tuesday, Nov.

The Bears Have it Backwards: Cramer's 'Mad Money' Recap (Monday 9/24/18)

The Bears Have it Backwards: Cramer's 'Mad Money' Recap (Monday 9/24/18)

Jim Cramer says traders hate hearing about long-term investing because they want instant payoffs.

Zoetis Takes Over #120 Spot From Harris

Zoetis Takes Over #120 Spot From Harris

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Zoetis Inc has taken over the #120 spot from Harris Corp. , according to ETF Channel.

Zoetis Declares Fourth Quarter 2018 Dividend

Zoetis Declares Fourth Quarter 2018 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a fourth quarter 2018 dividend payable to holders of the company's common stock of $0.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Zoetis To Host Webcast And Conference Call On Third Quarter 2018 Financial Results

Zoetis To Host Webcast And Conference Call On Third Quarter 2018 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

Zoetis Named A Top Company For Working Mothers

Zoetis Named A Top Company For Working Mothers

Zoetis Inc. (NYSE:ZTS) today announced that it has been named one of Working Mother Magazine's "100 Best Companies for Working Mothers" for the fifth consecutive year.

TheStreet Quant Rating: B+ (Buy)